共 18 条
- [1] TX-004HR vaginal estradiol has negligible to very low systemic absorption of estradiol MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (05): : 510 - 516
- [3] Evaluation of Systemic Effects of a Vaginal Estradiol Softgel Capsule (TX-004HR) in Menopausal Women with Moderate-to-Severe Dyspareunia MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (12): : 1485 - 1485
- [5] Significant Improvement in Vaginal Epithelium with TX-004HR in Postmenopausal Women with Moderate-to-Severe Vulvar and Vaginal Atrophy (VVA) and Dyspareunia MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (12): : 1372 - 1372
- [6] REJOICE Trial: TX-004HR Consistently Improved Vaginal Dryness in Subgroups of Postmenopausal Women with Vulvar and Vaginal Atrophy (VVA) and Dyspareunia MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (12): : 1444 - 1444
- [8] TX-004HR Improved Moderate-to-Severe Dyspareunia and Vaginal Dryness Associated with Vulvar and Vaginal Atrophy (VVA) in Post-menopausal Women MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (12): : 1443 - 1443
- [9] The Effect of Body Position on the Pharmacokinetics of TX-004HR, Estradiol Vaginal Softgel Capsule MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (12): : 1400 - 1400
- [10] A 17β-estradiol, Softgel, Vaginal Capsule (TX-004HR) had an Early Onset of Action for Treating Vulvar and Vaginal Atrophy (VVA) and Moderate-to-Severe Dyspareunia MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (12): : 1501 - 1501